Capitol Health Ltd. said that while it did not intend to increase how much it is willing to pay to acquire Integral Diagnostics Ltd., it did reserve the right to do so.
The company was responding to an article published in the Australian Financial Review that suggested Capitol Health was unlikely to change its bid.
"[I]t is not our current intention to substantially increase the offer," Capitol Health CEO and Managing Director Andrew Harrison was quoted as saying, adding that he did not intend to "chase" the target company.
"Capitol's present intention is not to increase the consideration under the offer, or to extend the period of the offer, but in each case, it reserves the right to do so," the company said in a statement.
The Australian diagnostic imaging facilities operator is offering 6.9 of its fully paid ordinary shares and 36 Australian cents in cash for each share of Integral — a bid that has been rejected by the target company's board.
